107 related articles for article (PubMed ID: 7923149)
1. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Satoh M; Cherian MG; Imura N; Shimizu H
Cancer Res; 1994 Oct; 54(20):5255-7. PubMed ID: 7923149
[TBL] [Abstract][Full Text] [Related]
2. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
Satoh M; Kloth DM; Kadhim SA; Chin JL; Naganuma A; Imura N; Cherian MG
Cancer Res; 1993 Apr; 53(8):1829-32. PubMed ID: 8467502
[TBL] [Abstract][Full Text] [Related]
3. [Role of metallothionein in cancer chemotherapy].
Naganuma A; Imura N
Gan To Kagaku Ryoho; 1994 Feb; 21(3):301-6. PubMed ID: 8109985
[TBL] [Abstract][Full Text] [Related]
4. Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors.
Saga Y; Hashimoto H; Yachiku S; Iwata T; Tokumitsu M
Int J Urol; 2004 Jun; 11(6):407-15. PubMed ID: 15157211
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor.
Shibuya K; Cherian MG; Satoh M
Radiat Res; 1997 Sep; 148(3):235-9. PubMed ID: 9291354
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes in glutathione and metallothionein in newborn rat liver.
Gallant KR; Cherian MG
J Pharmacol Exp Ther; 1989 May; 249(2):631-7. PubMed ID: 2566683
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor.
Kondo Y; Satoh M; Imura N; Akimoto M
Anticancer Res; 1992; 12(6B):2303-7. PubMed ID: 1295477
[TBL] [Abstract][Full Text] [Related]
8. Optimal administration schedule of cisplatin for bladder tumor with minimal induction of metallothionein.
Kondo Y; Yamagata K; Satoh M; Himeno S; Imura N; Nishimura T
J Urol; 2003 Dec; 170(6 Pt 1):2467-70. PubMed ID: 14634452
[TBL] [Abstract][Full Text] [Related]
9. Induction of metallothionein synthesis in transplanted murine tumors by X irradiation.
Shibuya K; Satoh M; Muraoka M; Watanabe Y; Oida M; Shimizu H
Radiat Res; 1995 Jul; 143(1):54-7. PubMed ID: 7597144
[TBL] [Abstract][Full Text] [Related]
10. [Metallothionein as a resistance factor for antitumor drugs].
Imura N; Naganuma A; Satoh M
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):599-604. PubMed ID: 2705789
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice.
Okazaki Y; Miura N; Satoh M; Imura N; Naganuma A
Biochem Biophys Res Commun; 1998 Apr; 245(3):815-8. PubMed ID: 9588197
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin.
Webber MM; Rehman SM; James GT
Cancer Res; 1988 Aug; 48(16):4503-8. PubMed ID: 3396002
[TBL] [Abstract][Full Text] [Related]
13. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
14. Hepatic zinc response via metallothionein induction after tumor transplantation.
Tamano H; Igasaki E; Enomoto S; Oku N; Itoh N; Kimura T; Tanaka K; Takeda A
Biochem Biophys Res Commun; 2000 Apr; 270(3):1140-3. PubMed ID: 10772964
[TBL] [Abstract][Full Text] [Related]
15. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
Koropatnick J; Pearson J
Mol Pharmacol; 1993 Jul; 44(1):44-50. PubMed ID: 8341278
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein null cells have increased sensitivity to anticancer drugs.
Kondo Y; Woo ES; Michalska AE; Choo KH; Lazo JS
Cancer Res; 1995 May; 55(10):2021-3. PubMed ID: 7743495
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum.
Kondo Y; Kuo SM; Lazo JS
J Pharmacol Exp Ther; 1994 Sep; 270(3):1313-8. PubMed ID: 7932184
[TBL] [Abstract][Full Text] [Related]
18. Prevention of carcinogenicity of anticancer drugs by metallothionein induction.
Satoh M; Kondo Y; Mita M; Nakagawa I; Naganuma A; Imura N
Cancer Res; 1993 Oct; 53(20):4767-8. PubMed ID: 8402657
[TBL] [Abstract][Full Text] [Related]
19. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
Caffrey PB; Zhang Y; Frenkel GD
Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines.
Kondo Y; Kuo SM; Watkins SC; Lazo JS
Cancer Res; 1995 Feb; 55(3):474-7. PubMed ID: 7834610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
